Skip to main content
Equibles

UBS Group AG

Position in LRMR — Larimar Therapeutics, Inc.

CIK 1610520 ZURICH, V8
Back to LRMR Full portfolio

Position in LRMR

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$440,194
+$306,549 QoQ
Shares Held
144,326
+386.0% QoQ
Ownership
0.139%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#45
of 162 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LRMR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,806 across 561 Biotechnology names. LRMR ranks #303 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 5,450,825 $1,020,369,609
2 ROIV
Roivant Sciences Ltd.
 17,466,641 $618,144,423
3 PTGX
Protagonist Therapeutics, Inc
 3,399,221 $416,676,508
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 712,259 $353,800,411
5 MRNA
Moderna, Inc.
 4,463,211 $312,558,664
6 INSM
INSMED Inc
 2,584,446 $275,553,630
7 ABVX
Abivax S.A.
 1,844,918 $245,853,771
8 MDGL
Madrigal Pharmaceuticals, Inc.
 401,708 $215,697,109

All Filings in LRMR

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $440,194 144,326
2026-03-31 $133,645 29,699
2025-12-31 $436,549 114,580
2025-09-30 $833,335 257,999
2025-06-30 $313,093 108,337
2025-03-31 $96,556 44,910
2024-12-31 $205,616 53,131
2024-09-30 $130,174 19,874
2024-06-30 $128,122 17,672
2024-03-31 $201,878 26,598
2023-12-31 $127,577 28,039
2023-09-30 $55,509 14,053
2023-06-30 $89,784 28,685
2023-03-31 $26,916 5,942
2022-12-31 $297 72
2022-09-30 $10,703 3,345
2022-06-30 $1,177 601
2022-03-31 $7,018 1,733
2021-12-31 $12,095 1,121
2021-09-30 $92 8
2021-06-30 $78 8
2021-03-31 $116 8
2020-12-31 $6,401 299